Sintx Technologies (SINT) Cash from Discontinued Operations (2017 - 2018)
Sintx Technologies' quarterly Cash from Discontinued Operations came in at 882000.0 in Q4 2018, down 47.84% year-on-year from 1691000.0 in Q4 2017, and up 352.31% quarter-over-quarter from 195000.0 in Q3 2018.
Sintx Technologies has reported Cash from Discontinued Operations for 2 years, with the latest figure at 882000.0 in Q4 2018.
- For the quarter ending Q4 2018, Cash from Discontinued Operations fell 47.84% year-over-year to 882000.0; the trailing twelve-month figure through Dec 2018 stood at 675000.0 (changed N/A YoY), and the FY2018 full-year result was 675000.0, down 72.42% from the prior year.
- Cash from Discontinued Operations for Q4 2018 stood at 882000.0, up from 195000.0 in the prior quarter.
- The five-year high for Cash from Discontinued Operations was 1691000.0 in Q4 2017, with the low at 616000.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 882,000.00 |
| Dec 31, 2018 | 882,000.00 |
| Sep 30, 2018 | 195,000.00 |
| Sep 30, 2018 | 195,000.00 |
| Jun 30, 2018 | -616,000.00 |
| Jun 30, 2018 | -616,000.00 |
| Mar 31, 2018 | 214,000.00 |
| Mar 31, 2018 | 214,000.00 |
| Dec 31, 2017 | 1.69 Mn |
| Dec 31, 2017 | 1.69 Mn |